Ace the Case: A 16-Year-Old Female Who Could Benefit From PrEP

0.50 CME
0.50 CPE
30 MINS
$0 FEE
SAVE
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

A 16-Year-Old Female Who Could Benefit From PrEP

Overview


Provider Statement

This continuing education activity is provided by Vindico Medical Education

Support Statement

This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.

Activity Description

HIV is an infection that can progress to AIDS if left untreated, posing a severe threat to an individual’s immune system. Although pre-exposure prophylaxis (PrEP) drugs are highly effective in preventing HIV transmission, less than 25% of eligible patients receive PrEP due to clinician knowledge gaps and confidence issues. Updated guidelines recommend offering PrEP to sexually active individuals at risk of HIV infection, including those with partners with an unknown HIV status or a history of sexually transmitted infections. Various PrEP options exist, including once-daily oral regimens and the recently approved long-acting injectable drug cabotegravir. Despite available options, there are disparities in PrEP uptake, particularly among specific populations, emphasizing the need for increased education and training of clinicians about barriers to use and patient discussions about PrEP. In this CE activity, expert faculty explain the efficacy, safety, availability, and appropriate use of HIV PrEP and identify disparities in the use of HIV PrEP based on race, geographical location, and other key social determinants of health.

Target Audience

The intended audience for this activity is family medicine practitioners, internists, pharmacists, nurse practitioners, physician associates, and other healthcare professionals involved in the management of patients at risk for HIV.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Explain the efficacy, safety, availability, and appropriate use of HIV PrEP.
  • Identify disparities in the use of HIV PrEP on the basis of race, geographical location, and other key social determinants of health.

Faculty

Meredith E. Clement, MD
Associate Professor
Infectious Diseases
Louisiana State University Health Sciences Center
New Orleans, LA

Medical Writer

Kaci Durbin, MD, MBA

Planners/Reviewers

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Jennifer Frederick, PharmD, BCPS
Linda A. Giarraputo, BS, PA-C

Accreditation

ACCME Jointly accredited In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

abim Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participants who opt in by providing their ABIM ID and DOB (MM/DD) will earn MOC points equivalent to the amount of CME credits claimed for the activity.

This program is acceptable for 0.50 contact hours of ACPE Continuing Education Credit. The ACPE Universal Program Number is JA0006104-0000-24-001-H02-P, effective 1/31/2024. This is a knowledge-based activity, and there is no fee to attend.

Vindico Medical Education will provide pharmacist credits claimed information directly to the ACPE through CPE Monitor within 30 days.

aapaVindico Medical Education has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.50 AAPA Category 1 CME credits. Approval is valid until 1/30/2025. PAs should only claim credit commensurate with the extent of their participation.

This enduring material is approved for 1 year from the date of original release, January 31, 2024, to January 30, 2025.

How to Participate in This Activity and Obtain CE Credit

To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the case, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering the posttest question correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™, AAPA Category 1 CME Certificate, or Statement of Continuing Pharmacy Education Credit.

Disclosures

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Relationship information is accurate at the time of content development.

Faculty reports the following relevant financial relationship(s)

Meredith E. Clement, MD
Advisor: ViiV
Independent Research Contractor (paid to institution): Gilead, ViiV

Medical Writer reports the following relevant financial relationship(s)

Kaci Durbin, MD, MBA
No relevant financial relationships to disclose.

Planners/Reviewers report the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Jennifer Frederick, PharmD, BCPS
No relevant financial relationships to disclose.

Linda A. Giarraputo, BS, PA-C
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relevant financial relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2024 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

Procedures for Reporting Copyright Infringement

If you suspect that any content in this activity violates your copyright, you can request the removal of such content or restrict access to it by contacting our designated copyright agent (as outlined below). To do so, kindly provide the following details:

  • Specify the copyrighted work you believe has been infringed upon.
  • Describe the work and, if possible, include the location (eg, URL) of an authorized version of the work.
  • Share your name, address, telephone number, and, if available, your email address.
  • Assert that you genuinely believe that the use of the materials in question is not authorized by the copyright owner, its agent, or the law.
  • Confirm that the information you have provided is accurate and send an attestation, "under penalty of perjury," that you are either the copyright owner or have the authority to act on behalf of the copyright owner.
  • Provide a signature or its electronic equivalent from the copyright holder or a representative authorized to act on their behalf.

Our agent for copyright issues relating to this web activity is as follows:
Vindico Medical Education, LLC
Attn: Faith Bantivoglio
6900 Grove Road, Building 300
Thorofare, NJ 08086
fbantivoglio@vindicocme.com
or call: 856-994-9400, ext. 614

CE Questions?

Contact us at cme@vindicoCME.com